Patents by Inventor Todd Randall Mereniuk

Todd Randall Mereniuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10087448
    Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: October 2, 2018
    Assignees: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, ALBERTA HEALTH SERVICES
    Inventors: Michael Weinfeld, Todd Randall Mereniuk, Edan Foley, Dennis G. Hall
  • Patent number: 9694073
    Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: July 4, 2017
    Assignees: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, ALBERTA HEALTH SERVICES
    Inventors: Michael Weinfeld, Dennis G. Hall, Feridoun Karimi-Busheri, Gary Kenneth Freschauf, Todd Randall Mereniuk
  • Publication number: 20160083732
    Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).
    Type: Application
    Filed: June 30, 2015
    Publication date: March 24, 2016
    Inventors: Michael WEINFELD, Todd Randall MERENIUK, Edan FOLEY, Dennis G. HALL
  • Publication number: 20150306219
    Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.
    Type: Application
    Filed: April 30, 2015
    Publication date: October 29, 2015
    Inventors: Michael WEINFELD, Dennis G. HALL, Feridoun KARIMI-BUSHERI, Gary Kenneth FRESCHAUF, Todd Randall MERENIUK
  • Patent number: 9115406
    Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: August 25, 2015
    Assignees: THE GOVENORS OF THE UNIVERSITY OF ALBERTA, ALBERTA HEALTH SERVICES
    Inventors: Michael Weinfeld, Todd Randall Mereniuk, Edan Foley, Dennis G. Hall
  • Patent number: 9040551
    Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: May 26, 2015
    Assignees: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA, ALBERTA HEALTH SERVICES
    Inventors: Michael Weinfeld, Dennis G. Hall, Feridoun Karimi-Busheri, Gary Kenneth Freschauf, Todd Randall Mereniuk
  • Publication number: 20130289095
    Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).
    Type: Application
    Filed: November 7, 2011
    Publication date: October 31, 2013
    Applicant: The Governors of the University of Alberta
    Inventors: Michael Weinfeld, Todd Randall Mereniuk, Edan Foley, Dennis G. Hall
  • Publication number: 20120142721
    Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.
    Type: Application
    Filed: June 4, 2010
    Publication date: June 7, 2012
    Applicants: ALBERTA HEALTH SERVICES, THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    Inventors: Michael Weinfeld, Dennis G. Hall, Feridoun Karimi-Busheri, Gary Kenneth Freschauf, Todd Randall Mereniuk